Your browser doesn't support javascript.
loading
Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment.
Paris, Alvar; Lake, Luke; Joseph, Albert; Workman, Anna; Walton, Joseph; Hayton, Tom; Evangelou, Nikos; Lilleker, James B; Ayling, Ruth M; Nicholl, David; Noyce, Alastair J.
Afiliación
  • Paris A; Preventive Neurology Unit, Centre for Prevention, Diagnosis and Detection, Wolfson Institute of Population Health, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Lake L; Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Joseph A; Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Workman A; Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Walton J; Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Hayton T; Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Evangelou N; Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Lilleker JB; Surgical Reconstruction and Microbiology Research Centre, National Institute for Health Research, Birmingham, UK.
  • Ayling RM; Academic Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Nicholl D; Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK.
  • Noyce AJ; Muscle Diseases Unit, Manchester Centre for Clinical Neurosciences, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Pract Neurol ; 23(3): 222-228, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36813556
Recreational use of nitrous oxide (N2O) has increased rapidly in recent years and is now the second most commonly used recreational drug among young people in the UK. There has been a corresponding rise in cases of nitrous oxide-induced subacute combined degeneration of the cord (N2O-SACD), a pattern of myeloneuropathy usually associated with severe vitamin B12 deficiency. This can cause serious and permanent disability in young people but, if recognised early, may be effectively treated. All neurologists should be aware of N2O-SACD and its treatment; however, there are currently no agreed guidelines. Based on our experience in East London, an area of high N2O use, we provide practical advice on its recognition, investigation and treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Deficiencia de Vitamina B 12 / Degeneración Combinada Subaguda Tipo de estudio: Diagnostic_studies / Guideline Límite: Adolescent / Humans Idioma: En Revista: Pract Neurol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Deficiencia de Vitamina B 12 / Degeneración Combinada Subaguda Tipo de estudio: Diagnostic_studies / Guideline Límite: Adolescent / Humans Idioma: En Revista: Pract Neurol Año: 2023 Tipo del documento: Article